A cross-sectional analysis of a Chinese population found that those in the highest adiponectin quartile showed an increased MetS risk (odds ratio (OR): 3.38, 95% CI: 2.56–4.46) over those in the lowest quartile [28]. Here, ADIPOQ is linked to metabolic syndrome.